Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Accounts Payables (2018 - 2025)

Historic Accounts Payables for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $9.9 million.

  • Verastem's Accounts Payables rose 12280.31% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 12280.31%. This contributed to the annual value of $4.0 million for FY2024, which is N/A changed from last year.
  • Per Verastem's latest filing, its Accounts Payables stood at $9.9 million for Q3 2025, which was up 12280.31% from $8.0 million recorded in Q2 2025.
  • Verastem's Accounts Payables' 5-year high stood at $9.9 million during Q3 2025, with a 5-year trough of $641000.0 in Q3 2021.
  • Moreover, its 5-year median value for Accounts Payables was $4.7 million (2022), whereas its average is $4.7 million.
  • As far as peak fluctuations go, Verastem's Accounts Payables tumbled by 8630.63% in 2021, and later skyrocketed by 73603.74% in 2022.
  • Verastem's Accounts Payables (Quarter) stood at $2.3 million in 2021, then surged by 112.9% to $4.9 million in 2022, then rose by 4.43% to $5.1 million in 2023, then fell by 21.34% to $4.0 million in 2024, then surged by 145.6% to $9.9 million in 2025.
  • Its Accounts Payables stands at $9.9 million for Q3 2025, versus $8.0 million for Q2 2025 and $7.2 million for Q1 2025.